Sonnet Biotherapeutics Holdings Inc Cash Flow-to-Debt Ratio
Sonnet Biotherapeutics Holdings Inc cash flow-to-debt ratio. Sonnet Biotherapeutics Holdings Inc (SONN) has a Cash Flow-to-Debt Ratio of -0.34x as of June 2025, meaning its operating cash flow of $-1.76 Million could theoretically repay 0% of its total liabilities ($5.10 Million) in one year. Check SONN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sonnet Biotherapeutics Holdings Inc (2009–2025)
Cash flow-to-debt ratio of Sonnet Biotherapeutics Holdings Inc from 2009 to 2025. Historical debt coverage capacity for Sonnet Biotherapeutics Holdings Inc across 15 annual periods. Check SONN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Sonnet Biotherapeutics Holdings Inc Cash Flow-to-Debt Ratio by Year (2009–2025)
Sonnet Biotherapeutics Holdings Inc cash flow-to-debt ratio by year from 2009 to 2025. Year-by-year debt coverage analysis for Sonnet Biotherapeutics Holdings Inc. For the full cash flow conversion analysis, see SONN cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.13x | $-12.83 Million | $4.10 Million | ▼ -18.5% |
| 2024 | -2.64x | $-8.61 Million | $3.26 Million | ▲ +30.0% |
| 2023 | -3.77x | $-21.34 Million | $5.66 Million | ▼ -14.1% |
| 2022 | -3.31x | $-27.69 Million | $8.37 Million | ▲ +1.2% |
| 2021 | -3.35x | $-22.55 Million | $6.73 Million | ▼ -6.7% |
| 2020 | -3.14x | $-15.61 Million | $4.97 Million | ▼ -306.9% |
| 2019 | -0.77x | $-2.23 Million | $2.89 Million | ▼ -1890.6% |
| 2017 | -0.04x | $-724.43K | $18.69 Million | ▼ -48.6% |
| 2016 | -0.03x | $-509.16K | $19.52 Million | ▲ +90.1% |
| 2015 | -0.26x | $-5.36 Million | $20.45 Million | ▼ -1.8% |
| 2015 | -0.26x | $-5.36 Million | $20.82 Million | ▲ +15.7% |
| 2013 | -0.31x | $-2.70 Million | $8.85 Million | ▼ -13.0% |
| 2012 | -0.27x | $-1.04 Million | $3.86 Million | ▼ -47264.5% |
| 2011 | 0.00x | $-760.31K | $1.33 Billion | ▲ +99.9% |
| 2009 | -0.87x | $-636.48K | $735.65K | — |